Ranimustine is a chloroethylnitrosourea derivative that inhibits proliferation and growth of tumor cells by alkylation and cross-linkage of DNA strands of tumor cells. (NCI). It is grouped under the following drug class(es): Alkylating agents. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Cymerin and Ranimustina. Its PubChem CID is 71741.
Ranimustine
| CAS No | 58994-96-0 |
|---|---|
| Molecular Formula | C10H18ClN3O7 |
| Molecular Weight | 327.72 g/mol |
| Synonyms | 1-(2-chloroethyl)-1-nitroso-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl]urea |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ranimustine is a chloroethylnitrosourea derivative that inhibits proliferation and growth of tumor cells by alkylation and cross-linkage of DNA strands of tumor cells.
The listed CAS number is 58994-96-0.
The listed molecular formula is C10H18ClN3O7.
The listed molecular weight is 327.72 g/mol.
1-(2-chloroethyl)-1-nitroso-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl]urea.
The source lists Cymerin and Ranimustina.